| http://www.w3.org/ns/prov#value | - The humanized antibodies of the present invention include complete antibody molecules having full length heavy and light chains, or any fragment thereof, such as the Fab or (Fab???)2 fragments, a heavy chain and light chain dimer, or any minimal fragment thereof such as an Fv, an SCA (single chain antibody), and the like that exhibits immunospecific binding for the Fc??RIIB. In ce
|
